Search

Search Results

Results 2491 - 2500 of 2691 for Autoimmune disorder

Scientists to present new findings from NIAID-funded research at ACAAI Annual Meeting

News - 12 Nov 2010

The 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) brings together leading allergists and immunologists from around the world.
New hope for those deaf from immune system attack

News - 16 Aug 2005

A new study may one day help those deafened by immune system attack, and possibly also lead to a test that could show which patients may be helped by immediate steroid treatment.
Vaccine prevents deadly pneumonia in African children

News - 28 Mar 2005

Global health leaders today presented new research showing that vaccinating infants against Streptococcus pneumoniae -- a bacterium that causes deadly pneumonia, meningitis and sepsis -- could...
Shingrix

Drug - 31 Mar 2026

Consumer Medicine Information (CMI) about Shingrix intended for persons living in Australia.
Remicade

Drug - 21 Jan 2026

Consumer Medicine Information (CMI) about Remicade intended for persons living in Australia.
Xadago

Drug - 5 Jan 2026

Consumer Medicine Information (CMI) about Xadago intended for persons living in Australia.
Melatonin Viatris

Drug - 4 Dec 2025

Consumer Medicine Information (CMI) about Melatonin Viatris intended for persons living in Australia.
Brenda-35 ED

Drug - 9 Oct 2025

Consumer Medicine Information (CMI) about Brenda-35 ED intended for persons living in Australia.
Abrilada

Drug - 6 Aug 2025

Consumer Medicine Information (CMI) about Abrilada intended for persons living in Australia.
Amgevita

Drug - 13 May 2025

Consumer Medicine Information (CMI) about Amgevita intended for persons living in Australia.

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.